Google stock (GOOG) flat after hours as Alphabet heads into earnings week, new cloud security deal in focus
30 January 2026
2 mins read

Google stock (GOOG) flat after hours as Alphabet heads into earnings week, new cloud security deal in focus

New York, Jan 29, 2026, 17:39 EST — After-hours

  • Alphabet’s non-voting Class C shares (GOOG) climbed before leveling off in after-hours trading
  • With Alphabet set to report on Feb. 4, investors are bracing as Big Tech’s AI spending draws sharper scrutiny
  • A new settlement involving Google and a fresh PwC-Google Cloud security initiative are shaking up the headlines

Alphabet Inc’s non-voting Class C shares (GOOG) climbed 0.7% during Thursday’s regular session, then held steady after hours at $338.66. After-hours trading takes place electronically following the 4 p.m. market close.

The stock is entering a packed earnings season for megacap tech, with investors demanding evidence that heavy AI investments are boosting revenue, not just adding costs. Spending by the largest tech companies is forecast to jump 30% this year, topping $500 billion. Alphabet stands out, buoyed by investor focus on Google’s Gemini 3 and a recent AI partnership with Apple, analysts say. “Alphabet has the upper hand in the AI race,” noted David Wagner, head of equities at Aptus Capital Advisors. 1

The mood has soured noticeably. Investors are hitting companies that boast about AI but ramp up capital expenditure—spending big on data centers, chips, and network capacity—without delivering growth to back it up. “The market appears to be questioning whether these massive capital expenditure hikes will generate sufficient returns,” said Jesse Cohen, a senior analyst at Investing.com. 2

PwC announced a three-year, $400 million collaboration investment with Google Cloud to boost AI-driven security operations. “Security professionals are under pressure to move faster and operate smarter,” said Morgan Adamski of PwC. Denise Walter from Google Cloud added the goal is to “translate agentic AI into real operational impact.” 3

Alphabet set a key date on its calendar: the company will release its fourth-quarter and full-year earnings in a conference call scheduled for Wednesday, Feb. 4, at 4:30 p.m. ET. Investors will be zeroing in on ad revenue trends, the pace of Google Cloud’s expansion, and how quickly expenses are climbing to back AI initiatives. 4

Legal news is making waves too. Google has agreed to a $135 million settlement in a proposed class action alleging that Android collected users’ cellular data without consent, though the company denies any misconduct. The deal still needs a judge’s green light and involves changes like securing consent during phone setup, simpler options to halt data transfers, and new disclosures in Google Play’s terms, according to a filing. 5

The risk for bulls is straightforward: expectations have soared. Should Alphabet’s earnings reveal a weaker ad market, slower cloud growth, or rising costs that pressure margins, the stock could lose ground fast.

Timing plays a role too. Security and cloud partnerships make headlines, but investors usually focus on revenue that hits the books quickly, rather than longer-term consulting and rollout projects.

Looking ahead to the next session, focus remains on the mixed signals from Big Tech earnings and evolving opinions on AI spending. Alphabet’s key date is Feb. 4, when it reports earnings followed by the 4:30 p.m. ET call.

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
New York, Feb 7, 2026, 10:22 EST — Market closed. Eli Lilly and Company shares closed Friday up $37.34, or 3.7%, at $1,058.18. The move came as U.S. regulators sharpened their tone on “compounded” weight-loss drugs — pharmacy-made versions meant for shortages or special patient needs that have morphed into mass-market alternatives. The FDA said it would take action against telehealth firm Hims & Hers over a $49 pill it marketed as a Wegovy-like option, and Lilly said it “applauded” the agency’s action. 1 Why it matters now: obesity and diabetes medicines have become the growth engine for large drugmakers,
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
ServiceNow stock sinks 10% after earnings as AI disruption fears batter software
Previous Story

ServiceNow stock sinks 10% after earnings as AI disruption fears batter software

Exxon Mobil stock jumps as oil hits five-month high on Iran fears, earnings up next
Next Story

Exxon Mobil stock jumps as oil hits five-month high on Iran fears, earnings up next

Go toTop